| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000042054 |
| Receipt No. | R000047954 |
| Scientific Title | Clinical study on nutritional matabolism and intestinal flora in patients with heart failure |
| Date of disclosure of the study information | 2020/11/01 |
| Last modified on | 2021/10/15 (Ver. 2) |
| Basic information | ||
| Public title | Clinical study on nutritional matabolism and intestinal flora in patients with heart failure | |
| Acronym | Clinical study on nutritional matabolism and intestinal flora in patients with heart failure | |
| Scientific Title | Clinical study on nutritional matabolism and intestinal flora in patients with heart failure | |
| Scientific Title:Acronym | Clinical study on nutritional matabolism and intestinal flora in patients with heart failure | |
| Region |
|
|
| Condition | ||
| Condition | heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will analyze the intestinal flora of patients with heart failure, confirm the severity of heart failure and the disorder of the intestinal flora, and clarify the involvement of cardiointestinal correlation in the nutritional metabolism pathology of heart failure. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Association between heart failure severity and gut flora, short-chain fatty acid levels |
| Key secondary outcomes | 1) Relationship between the severity of heart failure and endotoxin and procalcitonin concentrations
2) Relationship between muscle mass and body fat mass and intestinal flora and short-chain fatty acid concentration 3) Relationship between inflammatory cytokines and endotoxin, procalcitonin, and gut flora 4) Relationship between nutritional indicators at admission and inflammatory cytokines 5) Relationship between nutritional index at admission and endotoxin concentration 6) Relationship between nutritional index at admission, intestinal flora, and short-chain fatty acid concentration |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients undergoing inpatient treatment at the Department of Cardiology, Shiga University of Medical Science Hospital during the research period | |||
| Key exclusion criteria | 1) Those who do not agree
2) Minors 3) Patients with malignant tumor complications. If a malignant tumor is found after participating in the study, it will be excluded from the analysis. 4) Patients with chronic obstructive pulmonary disease, hyperthyroidism, hypothyroidism, serious infectious diseases, and other diseases that affect nutritional metabolism. 5) Patients with pacemakers 6) Patients being treated with antibiotics 7) Other patients that the doctor in charge deems inappropriate |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiga University of Medical Science Hospital | ||||||
| Division name | Division of Clinical Nutrition | ||||||
| Zip code | 520-2192 | ||||||
| Address | Seta Tsukinowa-cho, Otsu, Shiga, JAPAN 520-2192 | ||||||
| TEL | 077-548-2519 | ||||||
| sasaki@belle.shiga-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shiga University of Medical Science Hospital | ||||||
| Division name | Division of Clinical Nutrition | ||||||
| Zip code | 520-2192 | ||||||
| Address | Seta Tsukinowa-cho, Otsu, Shiga, JAPAN 520-2192 | ||||||
| TEL | 077-548-2519 | ||||||
| Homepage URL | |||||||
| sasaki@belle.shiga-med.ac.jp | |||||||
| Sponsor | |
| Institute | Division of Clinical Nutrition , Shiga University of Medical Science Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Division of Clinical Nutrition , Shiga University of Medical Science Hospital |
| Address | Seta Tsukinowa-cho, Otsu, Shiga, JAPAN 520-2192 |
| Tel | 077-548-2519 |
| sasaki@belle.shiga-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | 1) Relationship between the severity of heart failure and endotoxin and procalcitonin concentrations
2) Relationship between muscle mass and body fat mass and intestinal flora and short-chain fatty acid concentration 3) Relationship between inflammatory cytokines and endotoxin, procalcitonin, and gut flora 4) Relationship between nutritional indicators at admission and inflammatory cytokines 5) Relationship between nutritional index at admission and endotoxin concentration 6) Relationship between nutritional index at admission, intestinal flora, and short-chain fatty acid concentration |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000047954 |